Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 7—July 2015
Dispatch

Outbreak of Ciprofloxacin-Resistant Shigella sonnei Associated with Travel to Vietnam, Republic of Korea

Jin Seok Kim, Jae Joon Kim, Soo Jin Kim, Se-Eun Jeon, Ki Yeon Seo, Jun-Kil Choi, Nan-Ok Kim, Sahyun Hong, Gyung Tae Chung, Cheon-Kwon Yoo, Young-Taek Kim, Hyeng Il Cheun, Geun-Ryang Bae, Yeong-Hee Yeo, Gang-Ja Ha, Mi-Suk Choi, Shin-Jung Kang, and Junyoung KimComments to Author 
Author affiliations: Korea National Institute of Health, Cheongju-si, South Korea (J.S. Kim, S.J. Kim, S.E. Jeon, N.-O. Kim, S. Hong, G.T. Chung, C.-K. Yoo, S.-J. Kang, J. Kim); Gyeongsangnam-do Provincial Government, Changwon-si (J.J. Kim); Korea Centers for Disease Control and Prevention, Cheongju-si (K.Y. Seo, J.-K. Choi, Y.T. Kim, H.I. Cheun, G.-R. Bae); Gyeongsangnam-do Public Health and Environmental Research Institute, Changwon-si (Y.-H. Yeo, G.-J. Ha); Changnyeong Preservation of Health, Changnyeong-gun, South Korea (M.-S. Choi)

Main Article

Table

Susceptibility profiles of outbreak Shigella sonnei isolate from index case-patient and Escherichia coli transconjugant strain used for testing, South Korea, 2014

Antimicrobial agent(s) MIC, μg/mL
Shigella sonnei 14-5222 E. coli J53 E. coli J53, TC-14-5222
Nalidixic acid >128 4 4
Ciprofloxacin 8 <0.12 <0.12
Ampicillin >64 >64 >64
Ampicillin/sulbactam 16 4 16
Amoxicillin/clavulanate 16 8 16
Cefoxitin 4 4 4
Ceftazidime 8 <0.25 8
Cefotaxime 64 <0.25 64
Cefotaxime/clavulanate <0.12 <0.12 <0.12
Cefepime 4 <1 4
Ceftriaxone 128 <0.12 128
Cefpodoxime >32 0.5 >32
Cephalothin >64 32 >64
Meropenem <1 <1 <1
Imipenem <2 <2 <2
Piperacillin/tazobactam <4 <4 <4
Streptomycin >128 4 4
Tetracycline 128 <2 <2
Chloramphenicol 8 8 8
Trimethoprim/sulfamethoxazole >16 <1 <1
Gentamicin 2 <1 <1
Amikacin <4 <4 <4
Azithromycin 1 1 1

Main Article

Page created: June 16, 2015
Page updated: June 16, 2015
Page reviewed: June 16, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external